FDA won’t specify criteria for returning full approval to recalled baby formula

Published



The Food and Drug Administration is sidestepping questions about a voluntary product recall of highly demanded baby formula, issuing an emergency authorization without detailing how to achieve full approval after its removal from shelves.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.